# Cross-Model Validation Consensus — Session 2026-03-21-scout-007

**Target**: Fe-S cluster biogenesis x Circadian clock regulation
**Date**: 2026-03-21
**Hypotheses validated**: 5 (1 PASS + 4 CONDITIONAL_PASS from Quality Gate)

## Methodology

- **GPT-5.4 Pro** (reasoning_effort: high, 1526 seconds / ~25 min): Empirical validation —
  novelty verdict with literature retrieval plan, counter-evidence search, mechanism
  plausibility assessment, experimental design with minimal viable experiments, confidence
  update with justification. Deep extended reasoning produced 995 lines of analysis.
- **Gemini 3.1 Pro** (thinking: HIGH, 51 seconds): Structural analysis — formal mathematical
  mappings between fields, isomorphism classification, quantitative predictions from the
  structural bridge, verification approaches. 188 lines of structured output.

---

## Per-Hypothesis Consensus

---

### H2.1: IRP1 [4Fe-4S] Cluster Occupancy as Feeding-Entrained Iron-Redox Chronostat

**Quality Gate**: PASS (rubric 8/10)

| Dimension | GPT-5.4 Pro | Gemini 3.1 Pro | Consensus |
|-----------|-------------|----------------|-----------|
| Novelty | PARTIALLY EXPLORED — feeding-IRE axis known (Nadimpalli 2024), IRP1 cluster occupancy oscillation unshown | Structural correspondence (bistable dynamics) — no prior formal mapping of IRP1 as a non-autonomous dynamical system | New integration: upstream components (feeding, serum iron, IRP1 switching) are individually known; the linkage as a feeding-entrained chronostat is novel |
| Confidence | 6/10 (down from 7) | 8/10 | Range 6-8; empirical concerns (redox arm mismatch, IRP2 dominance) temper structural strength |
| Mechanism | MODERATE — iron arm plausible, redox arm mis-specified (NADPH not NADH), IRP2 may dominate in liver, hepatocyte ferritin buffering damps signal | Cusp catastrophe / Schmitt trigger model: IRP1 as bistable switch driven by phase-amplitude coupling of iron and redox oscillations; predicts hysteresis and phase-sensitivity | Mechanistically coherent as a bistable switch; turnover kinetics and IRP2 redundancy are the open questions; redox arm should be reframed around NADPH/GSH |
| Testability | MEDIUM-HIGH — IRP1 aconitase vs EMSA time-course in TRF mice + IRP2-KO background; C437S rescue in hepatocytes | In vitro hysteresis mapping: phase-shifted coupled oscillations of [Fe2+] and glutathione redox buffer, real-time fluorometric aconitase readout | Full experimental roadmap: GPT gives in vivo protocol (TRF + IRP2-KO), Gemini gives in vitro bifurcation mapping; complementary |

**Agreement areas**: Both models confirm the feeding-iron-redox pathway is real and that IRP1
aconitase/IRE-BP switching is mechanistically sound. Both identify the iron arm as the stronger
driver. Gemini's cusp catastrophe analysis predicts hysteresis and phase-angle sensitivity --
testable predictions that enrich the in vivo experimental design.

**Divergence areas**: GPT-5.4 Pro identifies three specific empirical concerns: (1) the redox
arm uses NADH but ISC assembly requires NADPH/FDX2, (2) IRP2 dominance in liver may mask IRP1
oscillation, (3) hepatocyte ferritin buffering damps the predicted 2-3 fold amplitude. Gemini's
structural analysis is agnostic to these kinetic and biochemical constraints and gives higher
confidence based on topological elegance.

**Combined recommendation**: **HIGH PRIORITY** -- strongest candidate in this session. Run
the in vitro hysteresis test (Gemini: phase-shifted iron + redox oscillations) and TRF/IRP2-KO
in vivo experiment (GPT: 6-timepoint liver time course) in parallel. Reframe the redox arm
around NADPH/thiol redox rather than NADH.

---

### H2.3: CISD2 [2Fe-2S] as Redox-Gated ER-Mitochondrial Calcium Timer

**Quality Gate**: CONDITIONAL_PASS (rubric 7/10)

| Dimension | GPT-5.4 Pro | Gemini 3.1 Pro | Consensus |
|-----------|-------------|----------------|-----------|
| Novelty | NOVEL -- zero prior publications linking CISD2 to circadian function confirmed | Formal isomorphism (Hodgkin-Huxley / Markov gating) -- no prior formal mapping of redox-gated MAM Ca2+ flux | Genuinely novel; confirmed by both models from independent analytical perspectives |
| Confidence | 3/10 (down from 5) | 9/10 | Range 3-9; widest confidence gap reflects structural elegance vs empirical fragility |
| Mechanism | LOW-to-MODERATE -- no direct NADH-to-CISD2 coupling known; cluster may be too stable for daily reversible switching; MAM Ca2+ has many stronger regulators (IP3R, MCU, VDAC); CISD2 KO phenotypes are pleiotropic | Formal isomorphism with voltage-gated ion channels -- Boltzmann distribution over redox potential; predicts frequency-dependent facilitation/depression and inactivation states in CISD2-mediated Ca2+ transfer | Structurally elegant (formal isomorphism is mathematically exact), biochemically fragile (no established coupling from circadian redox oscillation to CISD2 cluster state) |
| Testability | MEDIUM -- cell-based phase-resolved Ca2+ transfer assay with CISD2 KO/rescue + cluster-binding mutant + redox clamp | MAM Ca2+ flux measurement under oscillating redox potential (DTT/H2O2 microfluidics), fit to 3-state Markov kinetic model | Gemini's in vitro approach is faster (~2 weeks); GPT's cell-based approach is more physiologically relevant; execute in vitro first as go/no-go gate |

**Agreement areas**: Both models confirm genuinely high novelty. Gemini identifies a formal
isomorphism (Boltzmann/Fermi-Dirac conductance) that predicts specific, testable behaviors
(frequency-dependent facilitation, inactivation states) independently of the circadian angle.

**Divergence areas**: GPT-5.4 Pro drops confidence sharply (3/10) due to: (1) no known
biochemical route from circadian NAD+/NADH to CISD2 cluster, (2) cluster may be too stable
for daily reversible switching, (3) CISD2 cluster-independent Ca2+ gating is documented,
(4) many alternative MAM Ca2+ regulators exist. Gemini gives 9/10 based purely on the
mathematical isomorphism between redox-gated flux and voltage-gated channels -- this
confidence reflects structural depth, not empirical likelihood.

**Combined recommendation**: **PROMISING** -- gate with in vitro Ca2+ flux vs redox potential
curve first (Gemini verification approach, ~2 weeks). If the curve shows threshold/hysteresis
behavior consistent with Markov gating, proceed to cell-based circadian assays. If flat,
retire. Reframe redox input around thiol/GSH rather than NADH. Do not invest in mouse work
until in vitro phase is resolved.

---

### H2.6: CIA Pathway as LIP/ROS-Responsive Circadian Gate for Cytoplasmic Fe-S Proteome

**Quality Gate**: CONDITIONAL_PASS (rubric 7/10)

| Dimension | GPT-5.4 Pro | Gemini 3.1 Pro | Consensus |
|-----------|-------------|----------------|-----------|
| Novelty | PARTIALLY EXPLORED -- CIAO3 LIP/ROS sensitivity known (Maio & Rouault 2022), circadian extension unshown | Structural correspondence (max-flow min-cut / priority queueing) -- no prior formal mapping of CIA pathway as network bottleneck | Novel circadian extension of established biochemistry; Gemini adds a formal network-theory framework |
| Confidence | 4/10 (down from 5) | 7/10 | Range 4-7; the whole-proteome claim is too broad but the subset-gate version is defensible |
| Mechanism | MODERATE for subset, LOW for whole proteome -- stress-range LIP/ROS may not reflect circadian amplitudes; many clients are long-lived; upstream ISC export may be rate-limiting | Time-varying bottleneck in bipartite network: CIA capacity as function of LIP(t) and ROS(t); predicts non-linear "starvation hierarchy" where low-affinity proteins collapse first | Mechanistically novel framing: priority-queue model predicts non-linear hierarchy among clients, not uniform scaling -- this is more specific and testable than "coordinated 24h oscillation" |
| Testability | MEDIUM -- q4h CIAO3 co-IP + 55Fe incorporation into ABCE1 in synchronized hepatocytes; LIP/ROS clamp | Multiplexed mass spectrometry (thermal proteome profiling) under titrated LIP/ROS to measure apo vs holo states across the client hierarchy | Both viable; priority-queue prediction adds specificity -- test for differential client sensitivity (starvation hierarchy), not just amplitude |

**Agreement areas**: Both models confirm novelty and that CIAO3 LIP/ROS sensitivity is the
credible mechanistic basis. Gemini's network-flow reframing strengthens the testable
prediction: instead of looking for uniform oscillation, test for a non-linear starvation
hierarchy among CIA client proteins.

**Divergence areas**: GPT-5.4 Pro notes that (1) known CIAO3 regulation data come from
stress-range perturbations, not physiological circadian amplitudes, (2) many cytoplasmic
Fe-S clients are long-lived housekeeping proteins, (3) upstream ISC export may dominate.
Gemini's structural analysis does not engage with these empirical constraints.

**Combined recommendation**: **PROMISING** -- refine the prediction from whole-proteome gate
to starvation hierarchy among fast-turnover CIA clients. Test whether CIAO3 complex assembly
oscillates at all under restricted feeding (q4h co-IP), then measure differential client
maturation (pulse-SILAC or 55Fe time-series) to test the priority-queue prediction.

---

### H2.2: Frataxin-Gated Fe-S Assembly via Mitochondrial LIP in FTMT-Negative Tissues

**Quality Gate**: CONDITIONAL_PASS (rubric 6/10)

| Dimension | GPT-5.4 Pro | Gemini 3.1 Pro | Consensus |
|-----------|-------------|----------------|-----------|
| Novelty | NOVEL -- no direct literature linking FTMT-negative liver to circadian mitochondrial LIP/Fe-S assembly | Structural correspondence (Metabolic Control Analysis) -- FTMT as substrate buffer modulating flux control coefficient of frataxin | Novel integration of known tissue-specific expression with circadian iron dynamics; Gemini adds formal MCA framework |
| Confidence | 4/10 (down from 6) | 8/10 | Range 4-8; second-largest divergence -- structural correctness vs empirical contradiction |
| Mechanism | LOW-to-MODERATE -- FTMT absence does not equal unbuffered mito-LIP (liver has ferritin, PCBP, mitoferrin regulation); frataxin is allosteric activator not simple iron donor; FA carriers are asymptomatic; heart comparator is confounded | MCA formal mapping: FCC of frataxin on Fe-S assembly flux is mathematically inverse function of [FTMT]; predicts zero-order (buffered) vs first-order (unbuffered) tissue dependence on FXN | Formal MCA model is mathematically correct in principle; the key empirical premise (oscillating liver mito-LIP) lacks positive evidence and may have negative evidence |
| Testability | MEDIUM -- liver vs heart mito-LIP + Fe-S activity time-course; AAV-FTMT overexpression rescue | Steady-state ISC assembly flux with genetically controlled FTMT:FXN ratios; plot ln(J) vs ln([FXN]) to extract experimental FCC | Both feasible; GPT emphasizes measuring whether mito-LIP oscillates at all (prerequisite); Gemini gives the quantitative MCA test (consequence) |

**Agreement areas**: Both models agree that the circuit logic (FTMT as iron buffer modulating
frataxin dependence) is formally correct and the tissue-specificity angle is intellectually
compelling. The MCA framework (Gemini) provides a rigorous quantitative prediction.

**Divergence areas**: This is the session's sharpest divergence. GPT-5.4 Pro finds the key
empirical premise undermined: liver mitochondria have extensive iron buffering beyond FTMT, and
the frataxin "iron donor" framing oversimplifies its allosteric role. Gemini gives 8/10 because
the MCA mapping is mathematically sound -- but this reflects model elegance, not experimental
reality. The divergence is not a disagreement: they measure different things (structural
validity vs empirical grounding).

**Combined recommendation**: **NEEDS WORK** -- first establish whether liver mitochondrial
labile iron actually oscillates under restricted feeding. Verify FTMT expression across
candidate tissues before choosing a comparator. If mito-LIP is confirmed non-oscillatory,
retire the liver-specific hypothesis. The MCA framework remains valuable as a general model
for tissue-specific Fe-S sensitivity to frataxin deficiency.

---

### H2.7: Conserved Fe-S Requirement in Clock Neurons -- Drosophila to Mammalian SCN

**Quality Gate**: CONDITIONAL_PASS (rubric 6/10)

| Dimension | GPT-5.4 Pro | Gemini 3.1 Pro | Consensus |
|-----------|-------------|----------------|-----------|
| Novelty | PARTIALLY EXPLORED -- Drosophila precedent (Mandilaras 2012), no mammalian SCN follow-up in 14 years | Structural correspondence (reliability theory) -- Fe-S pool as repairable system with stress-dependent failure rate | Confirmed novel mammalian angle; Gemini adds formal reliability-theory framework with threshold failure prediction |
| Confidence | 5/10 (down from 6) | 7/10 | Range 5-7; moderate confidence with complementary experimental approaches |
| Mechanism | MODERATE -- SCN ATP demand is real; NFS1 KO is a sledgehammer (impairs respiration, lipoate, TCA broadly); SCN network may compensate; effect may be generic to active neurons, not clock-specific | Reliability/availability model: Fe-S pool availability A(t) depends on firing-rate-driven degradation vs ISC repair flux; predicts abrupt threshold failure (not gradual fade) when A(t) < A_crit | Both mechanisms are compatible: reliability model predicts the failure mode (abrupt threshold), GPT's concern about NFS1 bluntness identifies the specificity challenge; the question is whether clock failure precedes neuronal death |
| Testability | MEDIUM -- adult SCN-targeted AAV-Cre in Nfs1 flox/PER2::LUC mice; wheel-running + ex vivo slice + histology | Optogenetic sustained high firing + ISC machinery inhibitor; measure time-to-failure of circadian rhythm and fit to reliability equation | Both rigorous and complementary; GPT gives genetic approach, Gemini gives biophysical approach; the optogenetic design elegantly tests the metabolic bottleneck without genetic KO |

**Agreement areas**: Both models confirm genuine novelty of the mammalian extension and
moderate-to-good confidence. The 14-year gap between Mandilaras 2012 (Drosophila) and zero
mammalian follow-up is real and striking. Both approaches converge on the same core test:
does SCN Fe-S depletion disrupt rhythms before causing neuronal death?

**Divergence areas**: Minor. GPT-5.4 Pro emphasizes that NFS1 KO is too broad (affects
respiration, lipoate, TCA globally) and the effect may not be clock-specific. Gemini's
reliability framework predicts this bluntness is actually informative -- if failure follows
the threshold equation, the mechanism is metabolic supply exhaustion, not nonspecific
degeneration.

**Combined recommendation**: **PROMISING** -- cleanest experimental path in this session.
Two-stage design: (1) Avp-Cre NFS1 full KO in adult SCN with wheel-running + PER2::LUC +
histology timeline, (2) optogenetic sustained firing rate clamping + ISC overexpression
rescue to confirm the metabolic bottleneck mechanism. Publishable even with partial effect
given the Drosophila-to-mammalian conservation framing.

---

## Session Summary

### Confidence Comparison Table

| Hypothesis | Quality Gate | Original | GPT-5.4 Pro | Gemini 3.1 Pro | Combined Recommendation |
|------------|-------------|----------|-------------|----------------|------------------------|
| H2.1 IRP1 Chronostat | PASS (8/10) | 7/10 | 6/10 | 8/10 | **HIGH PRIORITY** |
| H2.3 CISD2 Ca2+ Timer | COND_PASS (7/10) | 5/10 | 3/10 | 9/10 | PROMISING -- gate with in vitro first |
| H2.6 CIA Pathway Gate | COND_PASS (7/10) | 5/10 | 4/10 | 7/10 | PROMISING -- refine to starvation hierarchy |
| H2.2 Frataxin/FTMT | COND_PASS (6/10) | 6/10 | 4/10 | 8/10 | **NEEDS WORK** -- verify mito-LIP oscillation |
| H2.7 SCN Clock Neurons | COND_PASS (6/10) | 6/10 | 5/10 | 7/10 | **PROMISING** -- clear experimental path |

### High-Priority Candidates

1. **H2.1 -- IRP1 Chronostat**: Only PASS verdict from Quality Gate; both models give
   moderate-to-high confidence (6-8 range); full experimental roadmap available combining
   in vivo TRF time-course (GPT) with in vitro hysteresis mapping (Gemini). The kinetic
   concerns about cluster turnover are addressable experimentally.

2. **H2.7 -- SCN Clock Neurons**: Clean 14-year gap in mammalian literature; complementary
   experimental approaches (genetic KO from GPT + optogenetic from Gemini); reliability
   model gives precise failure-mode prediction. Publishable even with partial effect.

### Divergence Investigation List

1. **H2.3 -- CISD2 Ca2+ Timer** (GPT 3/10 vs Gemini 9/10): Widest gap in the session.
   Gemini's formal isomorphism (Boltzmann/Markov gating) is mathematically exact. GPT finds
   no biochemical pathway from circadian NAD+/NADH to CISD2 cluster state. Resolution:
   in vitro Ca2+ flux vs redox potential curve (2 weeks). If threshold behavior exists,
   the isomorphism is real regardless of the coupling mechanism.

2. **H2.2 -- Frataxin/FTMT** (GPT 4/10 vs Gemini 8/10): Gemini's MCA model is formally
   correct. GPT questions whether the empirical premise holds (liver mito-LIP may not
   oscillate; FTMT absence may not be the dominant factor). Resolution: measure liver
   mitochondrial labile iron under restricted feeding before any mechanistic investment.

### Prioritized Next Steps

1. **H2.1** (HIGH PRIORITY): Run IRP1 in vitro cyclical iron/redox titration to test the
   cusp catastrophe hysteresis prediction (Gemini). Feasible in 4-6 weeks. If hysteresis
   is confirmed, proceed to TRF mouse experiment with IRP2-KO background (GPT). Reframe
   redox arm around NADPH/thiol redox.

2. **H2.7** (PROMISING): Design Avp-Cre NFS1 conditional KO protocol for adult SCN;
   meanwhile set up the optogenetic firing-rate clamping experiment as a parallel, orthogonal
   validation of the metabolic bottleneck (Gemini reliability model).

3. **H2.3** (PROMISING, gated): Execute Ca2+ flux vs GSH:GSSG redox clamping in
   MAM-enriched fractions or permeabilized cells -- 2-week go/no-go gate. Fit to 3-state
   Markov model (Gemini). If positive, proceed to cell-based circadian assay (GPT). If
   flat, retire.

4. **H2.6** (PROMISING, refined): Run q4h CIAO3 co-IP in synchronized hepatocytes to test
   whether CIA complex assembly oscillates at all. If yes, test the priority-queue starvation
   hierarchy (Gemini) across 3-5 CIA client proteins using pulse-SILAC (holo/apo ratios,
   not abundance).

5. **H2.2** (NEEDS WORK): First measure liver mitochondrial labile iron under restricted
   feeding with explicit photoperiod controls. Verify FTMT expression across candidate
   tissues. If mito-LIP is non-oscillatory, retire the liver hypothesis. The MCA framework
   may redirect to heart or neurons.

### Cross-Model Validation Insight

Gemini 3.1 Pro's structural analyses consistently generated additional mathematical frameworks
and testable predictions not present in the original hypotheses: cusp catastrophe for H2.1,
Markov gating for H2.3, priority queueing for H2.6, MCA for H2.2, and reliability theory for
H2.7. These enrich the experimental roadmap by providing quantitative predictions (hysteresis
curves, threshold failures, starvation hierarchies) that go beyond the qualitative mechanisms
in the hypothesis cards.

GPT-5.4 Pro's extended reasoning (25 minutes, 995 lines) provided deep empirical grounding:
identifying specific counter-evidence, biochemical mis-specifications (NADH vs NADPH), and
experimental design details down to mouse strain, sample size, and analysis method. The
combination of structural depth (Gemini) and empirical rigor (GPT) produces a more complete
assessment than either model alone.

**Key lesson**: When structural confidence (Gemini) and empirical confidence (GPT) diverge
strongly (H2.2, H2.3), the divergence itself is informative -- it identifies hypotheses where
the mathematical framework is sound but the biological instantiation is uncertain. These are
precisely the cases where a targeted in vitro experiment can resolve the gap.

---

_Generated by MAGELLAN Cross-Model Validator (Session 2026-03-21-scout-007)_
_GPT-5.4 Pro (reasoning_effort: high, 1526s) + Gemini 3.1 Pro (thinking: HIGH, 51s)_
